The Tamoxifen Citrate Tablets, cataloged under National Stock Number 6505-01-092-5321, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Mayne Pharma Commercial Llc. Government technical data includes 3 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 5 commercial cross-references from 4 manufacturers, enabling identification through both NSN and commercial part number lookups. 1 verified substitute exists in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-092-5321 |
| Primary Part Number | NDC51862-0642-60 |
| Item Name | Tamoxifen Citrate Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Mayne Pharma Commercial Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 60.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS TAMOXIFEN EQUIVALENT |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC51862-0642-60 PRIMARY | Mayne Pharma Commercial Llc (USA) |
| NOLVADEX | Astrazeneca Lp (USA) |
| NDC00038-0600-60 | Zeneca Inc Zeneca Pharmaceuticals Group Stuart Pharmaceuticals (USA) |
| NDC00591-2472-60 | Actavis Elizabeth Llc Dba Actavis Us Div Actavis Pharma, Inc. (USA) |
| NOLVADEX TABLETS | Astrazeneca Lp (USA) |
NSN 6505-01-092-5321 is a Tamoxifen Citrate Tablets, manufactured by Mayne Pharma Commercial Llc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-092-5321 has 5 cross-referenced part numbers: NDC51862-0642-60 (Mayne Pharma Commercial Llc), NOLVADEX (Astrazeneca Lp), NDC00038-0600-60 (Zeneca Inc Zeneca Pharmaceuticals Group Stuart Pharmaceuticals), NDC00591-2472-60 (Actavis Elizabeth Llc Dba Actavis Us Div Actavis Pharma, Inc.), NOLVADEX TABLETS (Astrazeneca Lp).
There is 1 known substitute for 6505-01-092-5321: 6505-01-425-7431. Verify interchangeability with system specifications before substitution.
Key specifications for NDC51862-0642-60: Special Features: NOTE: D; Part Name Assigned by Controlling Agency: TAMOXIFEN CITRATE TABLETS USP 10MG EQUIVALENT 60S BT; Primary Container Content Quantity: 60.000 TABLETS; Primary Container Type: BOTTLE. 5 total characteristics are documented in the Federal Logistics Information System.